In Brief: Morton Grove
This article was originally published in The Tan Sheet
Executive Summary
Morton Grove: Generic loperamide 5 mL oral solution cleared for marketing by FDA Aug. 28 and will be on store shelves by the end of September. The oral solution, indicated for the control and relief of acute nonspecific diarrhea, was deemed therapeutically equivalent to McNeil Consumer Products' Immodium A-D...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning